Mutational and immune gene expression profiling at relapse in patients (pts) treated with adjuvant dabrafenib plus trametinib (D + T) or placebo (pbo) in the COMBI-AD trial.

Reinhard Dummer, Georgina V. Long, Mario Mandalà et al.|Journal of Clinical Oncology|2018

Cited by 1